Alessy Saleh A, Alqahtani Saleh A, Vignat Jerome, Abuhmaidan Amid, Basmi Amani E L, Al Lawati Najla, Ali A-Nooh Ameera, Shelpai Wael, Alhomoud Samar, Al-Zahrani Ali, Bray Freddie, Znaor Ariana
Public Health Department, College of Health Sciences, Saudi Electronic University, Riyadh, Saudi Arabia.
Centre for Cancer, Society & Public Health, Faculty of Life Sciences and Medicine, King's College London, UK.
Cancer Med. 2024 Sep;13(17):e70141. doi: 10.1002/cam4.70141.
Cancer is a leading cause of morbidity and mortality in the Gulf Cooperation Council (GCC) countries. This study aims to provide cancer incidence and mortality estimates in 2020 in the GCC countries alongside future projections for 2040 to shape cancer control policy in the region.
The estimated numbers of new cancer cases and deaths were extracted from the GLOBOCAN database developed by the International Agency for Research on Cancer; new cancer cases, cancer deaths, and corresponding age-standardized incidence and mortality rates for the year 2020 are presented.
An estimated 42,475 new cancer cases and 19,895 deaths occurred in the GCC countries in 2020, with corresponding age-standardized incidence and mortality rates of 96.5 and 52.3 per 100,000, respectively. Female breast (16%), colorectal (13%), and thyroid (9%) were the most common types of cancer in the GCC countries, accounting for almost 40% of all cancer incidence. Colorectal (14%) followed by breast cancer (9%) were the leading causes of cancer death, though the magnitude of rates of the major cancer types varied substantially across the GCC countries. Even if we assume rates in the region will remain unchanged over the next two decades, the cancer burden in the GCC will increase by 116% (Saudi Arabia) to 270% (Qatar), reaching nearly 104,000 cancer cases by the year 2040.
The sharp increase in the estimated cancer incidence and mortality predicted over the next decades in the region requires workforce and financial planning for the healthcare systems in the constituent countries, alongside broader strengthening of national cancer prevention and control efforts.
癌症是海湾合作委员会（GCC）国家发病和死亡的主要原因。本研究旨在提供2020年海湾合作委员会国家的癌症发病率和死亡率估计数以及2040年的未来预测，以制定该地区的癌症控制政策。
从国际癌症研究机构开发的GLOBOCAN数据库中提取新癌症病例和死亡的估计数；列出2020年的新癌症病例、癌症死亡人数以及相应的年龄标准化发病率和死亡率。
2020年海湾合作委员会国家估计有42475例新癌症病例和19895例死亡，相应的年龄标准化发病率和死亡率分别为每10万人96.5例和52.3例。女性乳腺癌（16%）、结直肠癌（13%）和甲状腺癌（9%）是海湾合作委员会国家最常见的癌症类型，占所有癌症发病率的近40%。结直肠癌（14%）其次是乳腺癌（9%）是癌症死亡的主要原因，尽管主要癌症类型的发病率在海湾合作委员会国家之间差异很大。即使我们假设该地区的发病率在未来二十年保持不变，到2040年海湾合作委员会的癌症负担将增加116%（沙特阿拉伯）至270%（卡塔尔），癌症病例数接近104000例。
预计该地区未来几十年癌症发病率和死亡率将急剧上升，这需要各成员国医疗系统进行劳动力和财务规划，同时更广泛地加强国家癌症预防和控制工作。
